Last reviewed · How we verify
IVX-A12
At a glance
| Generic name | IVX-A12 |
|---|---|
| Sponsor | Icosavax, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Safety and Immunogenicity of IVX-A12 in Participants of 60 to 85 Years of Age (PHASE2)
- A Study of IVX-A12 in Adults Participants (PHASE2)
- Safety and Immunogenicity of IVX-A12 in Healthy Older Adults (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |